Aspire Biopharma Holdings, Inc.
ASBP
$0.483
-$0.0041-0.84%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.50K | 19.60K | -- | 11.20K | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 167.50K | 30.00K | -- | 35.00K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 184.00K | 49.60K | -- | 46.20K | -- |
|
|
|||||
| Total Current Assets | 184.00K | 49.60K | -- | 46.20K | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 5.01M | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 184.00K | 5.06M | -- | 46.20K | -- |
|
|
|||||
| Total Accounts Payable | 129.40K | 161.50K | -- | 172.80K | -- |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 853.10K | 445.40K | -- | 360.60K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 3.10K | 157.30K | -- | 600.00 | -- |
| Total Other Current Liabilities | 3.10K | 157.30K | -- | 600.00 | -- |
| Total Current Liabilities | 985.60K | 764.30K | -- | 534.00K | -- |
|
|
|||||
| Total Current Liabilities | 985.60K | 764.30K | -- | 534.00K | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 853.10K | 445.40K | -- | 360.60K | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 3.85M | -- | -- | -- |
| Total Liabilities | 985.60K | 4.62M | -- | 534.00K | -- |
|
|
|||||
| Common Stock & APIC | 1.24M | 2.24M | -- | 979.50K | -- |
| Retained Earnings | -2.04M | -1.80M | -- | -1.47M | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -801.60K | 442.00K | -- | -487.90K | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -801.60K | 442.00K | -- | -487.90K | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -801.60K | 442.00K | -- | -487.90K | -- |
|
|
|||||